TFOs Directly Targeting Amplified Oncogenic Drivers Promote Apoptosis

Article navigation

Research Watch| January 12 2022

Online ISSN: 2159-8290

Print ISSN: 2159-8274

2021

American Association for Cancer Research.

Cancer Discov (2022) 12 (1): OF6.

Abstract

Triplex-forming oligonucleotides (TFO) were used to directly target amplified HER2 loci in breast tumors.

2021

American Association for Cancer Research.

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.